Silicon Laboratories (SLAB)
(Delayed Data from NSDQ)
$116.58 USD
+2.78 (2.44%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $116.47 -0.11 (-0.09%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for Silicon Laboratories, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 439 | 1,192 | 2,039 | 725 | 726 |
Receivables | 29 | 71 | 98 | 95 | 76 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 194 | 100 | 49 | 67 | 73 |
Other Current Assets | 75 | 98 | 52 | 89 | 69 |
Total Current Assets | 738 | 1,461 | 2,239 | 976 | 944 |
Net Property & Equipment | 146 | 152 | 147 | 139 | 136 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 436 | 461 | 495 | 798 | 533 |
Deposits & Other Assets | 123 | 95 | 78 | 80 | 62 |
Total Assets | 1,443 | 2,169 | 2,958 | 1,993 | 1,675 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 58 | 90 | 47 | 55 | 39 |
Current Portion Long-Term Debt | 45 | 0 | 451 | 134 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 61 | 96 | 171 | 95 | 99 |
Total Current Liabilities | 164 | 186 | 669 | 285 | 138 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 530 | 0 | 429 | 368 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 71 | 49 | 77 | 80 | 54 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 234 | 764 | 746 | 794 | 560 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 17 | 0 | 0 | 204 | 134 |
Retained Earnings | 1,193 | 1,416 | 2,215 | 994 | 981 |
Other Equity | -1 | -11 | -2 | 2 | 1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 1,209 | 1,405 | 2,212 | 1,200 | 1,115 |
Total Liabilities & Shareholder's Equity | 1,443 | 2,169 | 2,958 | 1,993 | 1,675 |
Total Common Equity | 1,209 | 1,405 | 2,212 | 1,200 | 1,115 |
Shares Outstanding | 31.70 | 31.90 | 38.20 | 43.90 | 43.50 |
Book Value Per Share | 38.13 | 44.04 | 57.92 | 27.33 | 25.63 |
Fiscal Year End for Silicon Laboratories, Inc falls in the month of December.
All items in Millions except Per Share data.
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 339 | 333 | 439 | 417 | 506 |
Receivables | 41 | 33 | 29 | 102 | 98 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 166 | 198 | 194 | 168 | 146 |
Other Current Assets | 54 | 83 | 75 | 87 | 71 |
Total Current Assets | 600 | 646 | 738 | 774 | 821 |
Net Property & Equipment | 139 | 142 | 146 | 151 | 152 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 424 | 430 | 436 | 442 | 448 |
Deposits & Other Assets | 87 | 126 | 123 | 109 | 97 |
Total Assets | 1,250 | 1,344 | 1,443 | 1,475 | 1,519 |
Liabilities & Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 39 | 45 | 58 | 48 | 55 |
Current Portion Long-Term Debt | 0 | 0 | 45 | 45 | 80 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 61 | 67 | 61 | 72 | 83 |
Total Current Liabilities | 100 | 111 | 164 | 165 | 219 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 57 | 71 | 50 | 41 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 157 | 179 | 234 | 215 | 260 |
Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 39 | 30 | 17 | 0 | 0 |
Retained Earnings | 1,054 | 1,136 | 1,193 | 1,263 | 1,263 |
Other Equity | 0 | 0 | -1 | -3 | -4 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 1,093 | 1,166 | 1,209 | 1,260 | 1,259 |
Total Liabilities & Shareholder's Equity | 1,250 | 1,344 | 1,443 | 1,475 | 1,519 |
Total Common Equity | 1,093 | 1,166 | 1,209 | 1,260 | 1,259 |
Shares Outstanding | 32.20 | 31.90 | 31.70 | 31.70 | 31.80 |
Book Value Per Share | 33.95 | 36.54 | 38.13 | 39.75 | 39.59 |